|
Volumn 10, Issue 5, 2001, Pages 935-942
|
An update on nesiritide for treatment of decompensated heart failure
a a a |
Author keywords
Congestive heart failure; Natriuretic peptides; Vasodilators
|
Indexed keywords
BETA ADRENERGIC RECEPTOR;
DOBUTAMINE;
DOPAMINE;
GLYCERYL TRINITRATE;
INOTROPIC AGENT;
MILRINONE;
NATRIURETIC PEPTIDE TYPE A;
NATRIURETIC PEPTIDE TYPE C;
NESIRITIDE;
NITROPRUSSIDE SODIUM;
PEPTIDE HORMONE;
PHOSPHODIESTERASE;
PLACEBO;
UNCLASSIFIED DRUG;
ARTICLE;
BOLUS INJECTION;
BRADYCARDIA;
CHEMICAL PARAMETERS;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION FUNCTION;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG APPROVAL;
DRUG EFFECT;
DRUG SAFETY;
DRUG TOLERABILITY;
FOOD AND DRUG ADMINISTRATION;
HEART FAILURE;
HEMODYNAMIC MONITORING;
HUMAN;
HYPOTENSION;
INCIDENCE;
MULTICENTER STUDY;
PHARMACOLOGY;
PUBLICATION;
RANDOMIZED CONTROLLED TRIAL;
SYMPTOM;
TITRIMETRY;
UNITED STATES;
ATRIAL NATRIURETIC FACTOR;
CARDIOTONIC AGENTS;
CLINICAL TRIALS;
HEART FAILURE, CONGESTIVE;
HUMANS;
NATRIURETIC PEPTIDE, BRAIN;
|
EID: 0035013575
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.10.5.935 Document Type: Article |
Times cited : (38)
|
References (31)
|